Related Experiment Videos
[Glycosphingolipids of human aorta]
Bioorganicheskaia Khimiia
|October 1, 1986
Summary
Researchers identified the main gangliosides in human aorta, with N-acetylneuraminosyl-lactosylceramide (ganglioside GM3) being the primary component. Glycosphingolipid composition may change with atherosclerosis.
Area of Science:
- Biochemistry
- Glycobiology
- Human Physiology
Context:
- Gangliosides and neutral glycosphingolipids are crucial components of cell membranes.
- Understanding their composition in the human aorta is vital for cardiovascular research.
- Atherosclerosis is a major cardiovascular disease characterized by arterial wall changes.
Purpose:
- To elucidate the structures of major gangliosides and neutral glycosphingolipids in human aorta.
- To quantify the relative abundance of identified glycosphingolipids.
- To explore potential alterations in glycosphingolipid profiles associated with atherosclerosis.
Summary:
- The primary ganglioside in human aorta (intima and media) was identified as N-acetylneuraminosyl-lactosylceramide (ganglioside GM3), constituting 67% of the total.
- Other identified gangliosides include GM1, GD3, GD1a, and GT1, all featuring N-acetyl-neuraminosyl derivatives.
- Major neutral glycosphingolipids found were glucosylceramide, lactosylceramide, globotriaosylceramide, and globotetraosylceramide.
- Preliminary findings suggest that glycosphingolipid composition may vary in the presence of aortic atherosclerosis lesions.
Impact:
- Provides foundational data on human aortic glycosphingolipid composition.
- Establishes a baseline for future studies investigating glycosphingolipid roles in vascular health and disease.
- Offers insights into potential biomarkers or therapeutic targets related to atherosclerosis.